Source:http://linkedlifedata.com/resource/pubmed/id/14742371
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2004-1-26
|
| pubmed:abstractText |
Activation of mast cells and the systemic release of histamine is a common side effect of opioids. Nevertheless, fentanyl and its derivatives show only a slight activation of mast cells with a subsequent liberation of histamine and tryptase. In this study, we used intradermal microdialysis to assess whether this stimulatory effect of opioids on mast cells depends on the activation of opioid receptors. This new approach allowed us to measure the dose-dependent release of histamine and tryptase from mast cells and the subsequent vascular and sensory effect without systemic side effects in volunteers. The opiate codeine and the synthetic opioids meperidine, fentanyl, alfentanil, sufentanil, remifentanil, buprenorphine, and the opioid antagonist naloxone were tested. Only codeine and meperidine induced mast cell activation with the release of tryptase and histamine, leading to protein extravasation, flare reactions, and itch sensations. Because naloxone did not attenuate these effects, it is unlikely that mu-opioid receptors are involved in the activation of mast cells. IMPLICATIONS: Opioid effects on mast cells were assessed using intradermal microdialysis. Mast cell activation was seen with codeine and meperidine; no other opioid induced degranulation. Therefore, histamine release seen at large concentrations of potent micro agonists is caused by an unspecific effect rather than an activation of opioid receptors.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, mu,
http://linkedlifedata.com/resource/pubmed/chemical/Serine Endopeptidases,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptases
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0003-2999
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
98
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
364-70, table of contents
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:14742371-Adult,
pubmed-meshheading:14742371-Analgesics, Opioid,
pubmed-meshheading:14742371-Blood Vessels,
pubmed-meshheading:14742371-Capillary Permeability,
pubmed-meshheading:14742371-Cell Degranulation,
pubmed-meshheading:14742371-Dose-Response Relationship, Drug,
pubmed-meshheading:14742371-Double-Blind Method,
pubmed-meshheading:14742371-Erythema,
pubmed-meshheading:14742371-Female,
pubmed-meshheading:14742371-Histamine Release,
pubmed-meshheading:14742371-Humans,
pubmed-meshheading:14742371-Male,
pubmed-meshheading:14742371-Mast Cells,
pubmed-meshheading:14742371-Microdialysis,
pubmed-meshheading:14742371-Naloxone,
pubmed-meshheading:14742371-Narcotic Antagonists,
pubmed-meshheading:14742371-Receptors, Opioid, mu,
pubmed-meshheading:14742371-Regional Blood Flow,
pubmed-meshheading:14742371-Serine Endopeptidases,
pubmed-meshheading:14742371-Skin,
pubmed-meshheading:14742371-Tryptases
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin.
|
| pubmed:affiliation |
Department of Anesthesiology, University Hospital, Erlangen, Germany. blunk@physiologie1.uni-erlangen.de
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|